/15

EVLA (4/15 with
EVLAþHL

patients with GSV
>20 mm or SSV
>15 mm close to
deep junction

No severe adverse events (no EHIT or
DVT). Signiﬁcant improvement of
VCSS at 1 year (6 pre to 2 post
procedure)

Single center
prospective
observational
cohort study

Atasoy
20151